ArticleJournal of medicinal chemistry2014

4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency.

Claudia M Calvet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.